This phase III trial compares the effect of adding levocarnitine to standard chemotherapy versus (vs.) standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care…
- Investigator
- Brian Stover
- Ages
- 15 Years - 40 Years
- Sexes
- All